| Leucinostatin |
11 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
Positive |
IC50 |
131 |
| Leucinostatin |
2 μg inhibitor/ml |
|
spinach |
chloroplast |
|
Positive |
IC50 |
132 |
| Leucinostatin |
0.1-0.4 μg/mg protein |
|
rat |
isolated liver mitochondria |
|
Positive |
|
133 |
| efrapeptins |
0.56 mol/mol F1 |
|
bovine |
heart MF1-ATPase |
|
Positive |
IC50 |
134 |
| efrapeptins |
70 ng/ml |
|
C. asciculate |
MF1-ATPase |
|
Positive |
IC50 |
135 |
| efrapeptins |
0.3 μM |
|
human |
umbilical vein endothelial cell, nonmitochondrial ATP synthase |
|
Positive |
IC50 |
136 |
| efrapeptins |
0.5 μg/ml |
|
R. rubrum |
chromatophores |
|
Positive |
IC50 |
137 |
| efrapeptins |
0.05-0.5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
Positive |
IC50 |
138 |
| efrapeptins |
21.5 μM |
|
|
EF1-ATPase |
|
Positive |
ki |
139 |
| efrapeptins |
10 nM |
|
bovine |
heart MF1-ATPase |
|
Positive |
kd |
134 |
| efrapeptins |
2.4 mol inhibitor/mol enzyme |
|
bovine |
heart SMP-ATPase |
|
Positive |
complete inhibition |
134 |
| resveratrol |
27.7 μM |
|
rat |
brain SMP, ATP synthesis |
|
Positive |
|
140 |
| resveratrol |
14 μM |
|
rat |
liver MF1-ATPase |
|
Positive |
|
141 |
| resveratrol |
19 μM |
|
rat |
brain M F0F1-ATPase |
|
Positive |
|
140 |
| resveratrol |
6.4 μM |
|
bovine |
bovine heart MF1-ATPase |
|
Positive |
|
142 |
| resveratrol |
2 μM |
|
human |
human umbilical vein endothelial cell, nonmitochondrial ATP synthase, ATP synthesis |
|
Positive |
|
136 |
| Diethylstilbestrol |
10 μM |
|
rat |
liver MF0F1-ATPase |
|
Positive |
|
143 |
| Diethylstilbestrol |
10-25 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
|
141 |
| SITS |
∼1.3 μM |
|
V. parahaemolyticus |
F0F1-ATPase |
|
Positive |
|
144 |
| SITS |
25 μM |
|
V. parahaemolyticus |
F1-ATPase |
|
Positive |
95% inhibition |
145 |
| DIDS |
20.9 μM |
|
rat |
liver MF1ATPase |
|
Positive |
|
146 |
| quercetin |
5 kmol/mol |
|
bovine |
heart MF1-ATPase |
|
Positive |
IC50 |
147 |
| quercetin |
85 μM |
|
bovine |
heart MF1-ATPase |
|
Positive |
IC50 |
148 |
| quercetin |
180 μM |
|
bovine |
heart SMP-ATPase |
|
Positive |
IC50 |
148 |
| quercetin |
50 μM |
|
rat |
brain F0F1-ATPase |
|
Positive |
IC50 |
140 |
| quercetin |
3 μM |
|
rat |
liver F1-ATPase |
|
Positive |
IC50 |
141 |
| quercetin |
2 kmol/mola |
|
spinach |
CF1-ATPase |
|
Positive |
|
147 |
| quercetin |
2.6 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
Positive |
IC50 |
131 |
| quercetin |
0.2 mM |
|
pig |
heart MF1-ATPase |
|
Positive |
Ki |
149 |
| quercetin |
27 μM |
|
bovine |
heart MF1-ATPase |
|
Positive |
Kd |
147 |
| quercetin |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
Positive |
46% inhibition |
150 |
| kaempferol |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
140 |
| morin |
60 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
140 |
| apigenin |
105 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
140 |
| genistein |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
140 |
| genistein |
50 μM |
|
rat |
liver F1-ATPase |
|
Positive |
10% inhibition |
141 |
| Biochanin A |
65 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
140 |
| Daidzein |
127 μM |
|
rat |
brain MF0F1-ATPase |
|
Positive |
IC50 |
151 |
| Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
Positive |
IC50 |
152 |
| Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
Positive |
IC50 |
131 |
| Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
153 |
| Oligomycin |
0.3 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
Positive |
IC50 |
154 |
| Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
Positive |
Ki |
155 |
| Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
Positive |
Ki |
156 |
| Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
Positive |
95% inhibition |
157 |
| Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
Positive |
75% inhibition |
158 |
| peliomycin |
4.5 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
153 |
| venturicidin B |
9 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
Positive |
IC50 |
152 |
| mefloquine |
|
|
|
|
|
Positive |
|
35 |
| venturicidin B |
11 μg inhibitor/mg protein |
|
E. coli |
membrane-bound ATPase |
|
Positive |
IC50 |
152 |
| venturicidin B |
0.06-0.18 (A and B) and 11.0 (X) μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
159 |
| venturicidin B |
5-11 μg inhibitor/mg protein |
|
T. pyriformis |
|
|
Positive |
IC50 |
138 |
| venturicidin B |
0.13 μg inhibitor/mg protein |
|
|
|
|
Positive |
IC50 |
153 |
| venturicidin B |
3.0 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
Positive |
IC50 |
131 |
| venturicidin B |
0.5 μM |
|
spinach |
thylakoids |
|
Positive |
IC50 |
160 |
| venturicidin B |
0.5 μM |
|
spinach |
thylakoids, ATPase |
|
Positive |
IC50 |
160 |
| ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
153 |
| ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
Positive |
IC50 |
152 |
| ossamycin |
8 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
Positive |
IC50 |
154 |
| paroxetine |
|
|
|
|
|
Positive |
|
35 |
| apoptolidin |
4-5 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
Positive |
Ki |
161 |
| apoptolidin |
18 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
Positive |
IC50 |
154 |
| cytovaricin |
1 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
Positive |
IC50 |
154 |
| cytovaricin |
0.4 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
Positive |
Ki |
161 |
| ossamycin |
0.8 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
Positive |
mean |
184 |
| Tamoxifen |
|
|
|
|
|
Positive |
|
35 |
| Oligomycin |
|
|
|
|
|
Positive |
|
35 |
| Oligomycin |
8.7 |
|
|
LUHMES (Lund human mesencephalic) cells |
Glc–Gal–NeuriTox assay |
Positive |
EC25(NA) [Glc/Gal] |
326 |
| Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle, pH gradient formation |
|
Positive |
|
170 |
| Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| Oligomycin |
0.3 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
Positive |
IC50 |
170 |
| Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
Positive |
Ki |
170 |
| Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
Positive |
Ki |
170 |
| Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
Positive |
95% inhibition |
170 |
| Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
Positive |
75% inhibition |
170 |
| ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
pH gradient formation by membrane vesicle |
|
Positive |
IC50 |
170 |
| ossamycin |
8 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
Positive |
IC50 |
170 |
| ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| venturicidin B |
|
|
|
|
|
Positive |
|
170 |
| Bedaquiline |
|
|
|
|
|
Positive |
|
170 |
| tributyltin chloride |
200 nM |
|
E. coli and |
F0F1-ATPase |
|
Positive |
|
170 |
| tributyltin chloride |
200 nM |
|
I. tartaricus |
F0F1-ATPase |
|
Positive |
|
170 |
| tributyltin chloride |
1 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
Positive |
47% inhibition |
170 |
| tributyltin chloride |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
Positive |
87% inhibition |
170 |
| tributyltin chloride |
1 μM |
|
|
TF0F1-ATPase |
|
Positive |
80% inhibition |
170 |
| NCCD |
0.65 nmol/mg protein |
|
bovine |
heart SMP-ATPase |
|
Positive |
IC50 |
170 |
| NCCD |
1 nmol NCCD/mg protein |
|
bovine |
heart SMP-ATPase |
|
Positive |
85% inhibition |
170 |
| substrate analogs |
|
|
|
|
|
Positive |
|
170 |
| tentoxin |
∼0.6 mol/mol |
|
spinach |
CF1-ATPase |
|
Positive |
IC50 |
170 |
| tentoxin |
50 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
Positive |
IC50 |
170 |
| tentoxin |
0.4-0.6 μM |
|
lettuce |
chloroplasts, photophosphorylation |
|
Positive |
IC50 |
170 |
| tentoxin |
10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
Positive |
Ki |
170 |
| tentoxin |
30-60 μM |
|
|
TF1-ATPase |
|
Positive |
Ki |
170 |
| tentoxin |
8-10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
Positive |
Kd |
170 |
| efrapeptins |
|
|
|
|
|
Positive |
|
170 |
| azide |
|
|
|
|
|
Positive |
|
170 |
| resveratrol |
|
|
|
|
|
Positive |
|
170 |
| N,N'-dicyclohexylcarbodiimide |
0.2 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| N,N'-dicyclohexylcarbodiimide |
1-5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| N,N'-dicyclohexylcarbodiimide |
200 μMa in less than 5 min and at ∼40 μMa in 30 min |
|
R. rubrum |
F1-ATPase |
|
Positive |
|
170 |
| N,N'-dicyclohexylcarbodiimide |
1.9 μg/mg protein |
|
C. fasciculata |
SMP-ATPase |
|
Positive |
IC50 |
170 |
| Oligomycin |
8 nM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
IC50 |
3 |
| aurovertin B |
1.5 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
IC50 |
3 |
| N,N'-dicyclohexylcarbodiimide |
1 mol DCCD/mol F1 |
|
|
EF1-ATPase |
|
Positive |
95% inhibition |
170 |
| N,N'-dicyclohexylcarbodiimide |
30 μM |
|
|
membrane-bound EF0F1-ATPase |
|
Positive |
maximal 70-80% inhibition |
170 |
| N,N'-dicyclohexylcarbodiimide |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
Positive |
47% inhibition |
170 |
| N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor bound/mol F1 |
|
bovine |
heart MF1-ATPase |
|
Positive |
97% inhibition |
170 |
| Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
bovine |
heart SMP-ATPase |
|
Positive |
maximal inhibition |
170 |
| N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor/mol F0 |
|
bovine |
heart H+-translocation |
|
Positive |
maximal inhibition |
170 |
| N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
E. coli |
membrane H+-translocation |
|
Positive |
maximal inhibition |
170 |
| woodward's reagent k |
|
|
|
|
|
Positive |
|
170 |
| Benoxaprofen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| N,N'-dicyclohexylcarbodiimide |
|
|
|
|
|
Positive |
|
170 |
| woodward's reagent k |
|
|
|
|
|
Positive |
|
170 |
| Bezafibrate |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Enterostatin |
|
|
|
|
|
Positive |
|
170 |
| ethyldimethylaminopropyl carbodiimide |
13 mol of EDC/mol F1 (EF1-ATPase) |
|
|
|
|
Positive |
95% inhibition |
170 |
| 1,5-difluoro-2,4-dinitrobenzene |
|
|
|
|
|
Positive |
|
170 |
| Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| NBD-Cl |
|
|
|
|
|
Positive |
|
170 |
| NBD-Cl |
|
|
|
|
|
Positive |
|
170 |
| Mersalyl |
130 μM |
|
bovine |
heart MF0, proton conductivity |
|
Positive |
70% inhibition |
170 |
| Dantrolene |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Diclofenac |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.01 |
3 |
| cyclophilin D |
|
|
|
|
|
Positive |
|
171 |
| Fluconazole |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| gefitinib |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| Linezolid |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Metformin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| pravastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Primaquine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| radicicol |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Rosiglitazone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
p < 0.001 |
3 |
| Diazepam |
140μg/ml |
|
|
PE cells |
potentiometric method |
Positive |
inhibit 60% |
293 |
| trazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Trovafloxacin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Negative |
p < 0.05 |
3 |
| Peroxynitrite |
2mM, IC50=0.63mM |
|
rat |
heart mitochondria |
ATPase activity was assayed by coupling to the reactions of pyruvate kinase with lactace dehydrogenase following NADH oxidation at 340nm |
Positive |
IC50 |
298 |
| Tamoxifen |
1.6 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
IC50 |
3 |
| Tamoxifen |
29 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
IC50 |
3 |
| Tamoxifen |
26 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
Positive |
IC50 |
3 |